Target intelligence / Profile preview

Pathogenic bacteria (RUDN bacteriophage complex targets)

Molecular classification
Other
01

Overview

The target 'Pathogenic bacteria targeted by RUDN bacteriophage complex' refers to a specific group of bacterial pathogens, including Staphylococcus, Streptococcus, Proteus, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli, which are susceptible to lytic phage cocktails studied at RUDN University (Peoples' Friendship University of Russia) (RUDN University, 2023). These bacteria are major drivers of pyoinflammatory diseases such as wound infections, respiratory tract infections, and sepsis (Microgen, 2022). The RUDN bacteriophage complex (often associated with the commercial 'Complex Bacteriophage' or 'Pyobacteriophage') targets these organisms by binding to specific surface receptors and initiating a lytic cycle that results in bacterial cell death (NIH, 2021). This approach is a critical area of research for addressing multi-drug resistant (MDR) infections where traditional antibiotics fail (PubMed, 2020). However, therapeutic challenges include the potential for bacteria to develop phage resistance and the risk of systemic inflammatory responses due to the release of endotoxins during rapid bacterial lysis (StatPearls, 2023).

Other names
Pyoinflammatory bacteriaBacteriophage complex targetsRUDN phage targetsComplex bacteriophage targets
02

Mechanism of action

Bacterial cell lysis via the lytic cycle of bacteriophages, involving adsorption to surface receptors, genome injection, and host cell hijacking.

03

Biological functions

Cell deathOther
04

Disease associations

InfectionInflammation
05

Safety considerations

Endotoxin release (Jarisch-Herxheimer-like reaction)Development of phage resistanceHost immune response to phage proteins
06

Interacting drugs

RUDN Bacteriophage Complex

2 more in the full profile.

07

Biomarkers

Phage susceptibility testingBacterial culture sensitivityProcalcitonin

Beyond the preview

Go deeper on Pathogenic bacteria (RUDN bacteriophage complex targets).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic bacteria (RUDN bacteriophage complex targets).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call